Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:18   Issue: 2
Pp: 133-133
Tetsumei Urano
DOI: 10.2174/138945011802161229204104



Editorial (Thematic Issue: Natural and Synthetic Polyphenols as Emerging Drugs: Design, Delivery Systems and Preclinical & Clinical Therapeutic Approaches) free to download

Volume:18   Issue: 2
Pp: 134-134
Teresa Puig
DOI: 10.2174/138945011802161229204226



Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents

Volume:18   Issue: 2
Pp: 147-159
Ramon Colomer, Ariadna Sarrats, Ruth Lupu and Teresa Puig
DOI: 10.2174/1389450117666160112113930



Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease

Volume:18   Issue: 2
Pp: 174-195
Laura Xicota, Jose Rodriguez-Morato, Mara Dierssen and Rafael de la Torre
DOI: 10.2174/1389450116666150825113655



Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer

Volume:18   Issue: 2
Pp: 232-253
Javadi Monisha, Nand Kishor Roy, Devivasha Bordoloi, Amit Kumar, Ramesh Golla, Jibon Kotoky, Ganesan Padmavathi and Ajaikumar B. Kunnumakkara
DOI: 10.2174/1389450117666160201112330